These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8346722)

  • 1. Clinical pharmacokinetics of sotalol.
    Hanyok JJ
    Am J Cardiol; 1993 Aug; 72(4):19A-26A. PubMed ID: 8346722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic profiles of d-sotalol and d,l-sotalol.
    Funck-Brentano C
    Eur Heart J; 1993 Nov; 14 Suppl H():30-5. PubMed ID: 7904936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sotalol: a breakthrough antiarrhythmic?
    Nappi JM; McCollam PL
    Ann Pharmacother; 1993 Nov; 27(11):1359-68. PubMed ID: 8286812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia.
    Saul JP; Schaffer MS; Karpawich PP; Erickson CC; Epstein MR; Melikian AP; Shi J; Karara AH; Cai B; Hinderling PH
    J Clin Pharmacol; 2001 Jan; 41(1):35-43. PubMed ID: 11144992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of (+/-)-sotalol in healthy male volunteers.
    Kimura M; Umemura K; Ikeda Y; Kosuge K; Mizuno A; Nakanomyo H; Ohashi K; Nakashima M
    Br J Clin Pharmacol; 1996 Nov; 42(5):583-8. PubMed ID: 8951189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacokinetic-pharmacodynamic model of d-sotalol Q-Tc prolongation during intravenous administration to healthy subjects.
    Salazar DE; Much DR; Nichola PS; Seibold JR; Shindler D; Slugg PH
    J Clin Pharmacol; 1997 Sep; 37(9):799-809. PubMed ID: 9549633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption kinetics of oral sotalol combined with cisapride and sublingual sotalol in healthy subjects.
    Deneer VH; Lie-A-Huen L; Kingma JH; Proost JH; Kelder JC; Brouwers JR
    Br J Clin Pharmacol; 1998 May; 45(5):485-90. PubMed ID: 9643622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sotalol: a new class III antiarrhythmic agent.
    Zanetti LA
    Clin Pharm; 1993 Dec; 12(12):883-91. PubMed ID: 8137605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers.
    Poirier JM; Jaillon P; Lecocq B; Lecocq V; Ferry A; Cheymol G
    Eur J Clin Pharmacol; 1990; 38(6):579-82. PubMed ID: 2373132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetic and pharmacodynamic properties of oral and intravenous (+)-sotalol in healthy volunteers.
    Uematsu T; Kanamaru M; Nakashima M
    J Pharm Pharmacol; 1994 Jul; 46(7):600-5. PubMed ID: 7996391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a safe intravenous sotalol dosing regimen.
    Somberg JC; Preston RA; Ranade V; Molnar J
    Am J Ther; 2010; 17(4):365-72. PubMed ID: 20562595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of flecainide.
    Conard GJ; Ober RE
    Am J Cardiol; 1984 Feb; 53(5):41B-51B. PubMed ID: 6364769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between sotalol and an antacid preparation.
    Läer S; Neumann J; Scholz H
    Br J Clin Pharmacol; 1997 Mar; 43(3):269-72. PubMed ID: 9088581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioavailability of sotalol in short bowel syndrome].
    Silomon M; Bach F; Juckenhöfel S; Claus T; Molter G
    Med Klin (Munich); 1999 Nov; 94(11):638-41. PubMed ID: 10603736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of tenoxicam.
    Nilsen OG
    Clin Pharmacokinet; 1994 Jan; 26(1):16-43. PubMed ID: 8137596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class III antiarrhythmics in overdose. Presenting features and management principles.
    Leatham EW; Holt DW; McKenna WJ
    Drug Saf; 1993 Dec; 9(6):450-62. PubMed ID: 8129865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic profile of nicorandil in humans: an overview.
    Frydman A
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S34-44. PubMed ID: 1282174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.